KRKA, TOVARNA ZDRAVIL D.D. - Proposed dividend for Krka shareholders 13.6% higher than last year

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Proposed dividend for Krka shareholders.pdfProposed dividend for Krka shareholders
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 17 / 2024

Date of issue: 2024-04-04

Short name of the issuer

KRKA

Subject

Proposed dividend for Krka shareholders 13.6% higher than last year

Official market - legal basis

art. 17. 1 MAR.

Unofficial market - legal basis

Contents of the report:

Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto informs the public on the proposed allocation of the 2023 accumulated profit.

The document is attached.


The notice will be published on the Company's website (www.krka.biz) from 4 April 2024 onwards, for a period of at least 5 years.

Annexes

File Description

Proposed dividend for Krka shareholders.pdfProposed dividend for Krka shareholders.pdf Proposed dividend for Krka shareholders

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

8501 Nove Mesto

(post code) (city)

Smarjeska 6

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nie dotyczy

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2024-04-04 Jože Colarič President of the Management Board and CEO